Florent Malard

8.9k total citations · 2 hit papers
145 papers, 3.6k citations indexed

About

Florent Malard is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Florent Malard has authored 145 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Hematology, 52 papers in Oncology and 35 papers in Immunology. Recurrent topics in Florent Malard's work include Hematopoietic Stem Cell Transplantation (83 papers), Acute Myeloid Leukemia Research (28 papers) and Multiple Myeloma Research and Treatments (24 papers). Florent Malard is often cited by papers focused on Hematopoietic Stem Cell Transplantation (83 papers), Acute Myeloid Leukemia Research (28 papers) and Multiple Myeloma Research and Treatments (24 papers). Florent Malard collaborates with scholars based in France, United States and Italy. Florent Malard's co-authors include Mohamad Mohty, Béatrice Gaugler, Jean‐Luc Harousseau, Abdul Hamid Bazarbachi, Rama Al Hamed, Philippe Moreau, Éolia Brissot, Patrice Chevallier, Thierry Guillaume and Bipin N. Savani and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Florent Malard

134 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acute lymphoblastic leukaemia

2020 434 citations Florent Malard, Mohamad Mohty profile →
Acute graft-versus-host disease

2023 100 citations Florent Malard, Ernst Holler et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Florent Malard France	32	2.1k	1.1k	1.0k	946	643	145	3.6k
Grzegorz Basak Poland	30	1.7k 0.8×	1.2k 1.1×	880 0.9×	735 0.8×	461 0.7×	164	3.7k
Mitchell E. Horwitz United States	31	2.5k 1.2×	947 0.8×	726 0.7×	1.3k 1.4×	526 0.8×	144	3.8k
Giuseppe Milone Italy	31	2.2k 1.0×	851 0.8×	1.2k 1.1×	466 0.5×	553 0.9×	142	3.2k
Bernd Gruhn Germany	38	1.7k 0.8×	976 0.9×	1.1k 1.0×	788 0.8×	891 1.4×	138	3.9k
Hee‐Je Kim South Korea	26	2.0k 0.9×	736 0.7×	605 0.6×	717 0.8×	601 0.9×	271	3.0k
Denis Guyotat France	31	1.9k 0.9×	1.0k 0.9×	956 0.9×	553 0.6×	646 1.0×	124	3.4k
Dirk Schwabe Germany	30	1.2k 0.6×	1.2k 1.1×	683 0.7×	1.4k 1.5×	633 1.0×	105	3.7k
Tetsuya Eto Japan	34	1.9k 0.9×	886 0.8×	566 0.5×	1.1k 1.2×	525 0.8×	263	3.9k
Michael Potter United Kingdom	32	1.8k 0.8×	767 0.7×	710 0.7×	675 0.7×	760 1.2×	116	3.3k
Kenneth F. Bradstock Australia	37	2.3k 1.1×	1.3k 1.1×	1.4k 1.3×	1.3k 1.4×	872 1.4×	156	4.7k

Countries citing papers authored by Florent Malard

Since Specialization

Citations

This map shows the geographic impact of Florent Malard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florent Malard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florent Malard more than expected).

Fields of papers citing papers by Florent Malard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florent Malard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florent Malard. The network helps show where Florent Malard may publish in the future.

Co-authorship network of co-authors of Florent Malard

This figure shows the co-authorship network connecting the top 25 collaborators of Florent Malard. A scholar is included among the top collaborators of Florent Malard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florent Malard. Florent Malard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Battipaglia, Giorgia, Claudia Wehr, Rick Admiraal, et al.. (2025). Usage of rabbit anti-thymocyte / anti-T-lymphocyte globulins (ATG / ATLG) for hematological malignancies in allogeneic hematopoietic cell transplantation: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines Committee. Bone Marrow Transplantation. 61(2). 128–141.

Michonneau, David, Florent Malard, Léonardo Magro, et al.. (2025). Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation. 60(6). 779–786. 4 indexed citations

Malard, Florent, Ernst Holler, Zinaida Perić, et al.. (2025). Microbiotherapy and fecal microbiota transplantation in hematology-oncology: a European clinical perspective to navigate the evolving regulatory framework and the emergence of a new therapeutic class. Bone Marrow Transplantation. 61(2). 125–127.

Secondino, Simona, Manuela Badoglio, Gianantonio Rosti, et al.. (2024). High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT. ESMO Open. 9(9). 103692–103692. 2 indexed citations

Brissot, Éolia, Myriam Labopin, Hélène Labussière, et al.. (2024). Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial. Blood Cancer Journal. 14(1). 31–31. 12 indexed citations

Arrieta‐Bolaños, Esteban, Tobias Gedde‐Dahl, Marie Robin, et al.. (2024). Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS. Blood. 144(16). 1747–1751. 4 indexed citations

Paviglianiti, Annalisa, Joël Gozlan, Éolia Brissot, et al.. (2024). Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impact. PubMed. 6(1). 26–38. 1 indexed citations

Mohty, Mohamad, Thierry Façon, Florent Malard, & Jean‐Luc Harousseau. (2024). A roadmap towards improving outcomes in multiple myeloma. Blood Cancer Journal. 14(1). 135–135. 4 indexed citations

Mohty, Mohamad, Hervé Avet‐Loiseau, Florent Malard, & Jean‐Luc Harousseau. (2023). Potential future direction of measurable residual disease evaluation in multiple myeloma. Blood. 142(18). 1509–1517. 11 indexed citations

10.

Duléry, Rémy, Florent Malard, Éolia Brissot, et al.. (2023). Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation. Bone Marrow Transplantation. 58(11). 1215–1222. 13 indexed citations

11.

Cheikh, Jean El, Nour Moukalled, Florent Malard, Ali Bazarbachi, & Mohamad Mohty. (2023). Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapies. Blood Cancer Journal. 13(1). 83–83. 19 indexed citations

12.

Malard, Florent & Mohamad Mohty. (2023). Updates in chronic graft‐versus‐host disease management. American Journal of Hematology. 98(10). 1637–1644. 20 indexed citations

13.

Malard, Florent, Ernst Holler, Brenda M. Sandmaier, He Huang, & Mohamad Mohty. (2023). Acute graft-versus-host disease. Nature Reviews Disease Primers. 9(1). 27–27. 100 indexed citations breakdown →

14.

Bazarbachi, Abdul Hamid, Rama Al Hamed, Florent Malard, et al.. (2022). Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update. Blood Cancer Journal. 12(3). 47–47. 22 indexed citations

15.

Ye, Yishan, Florent Malard, Jimin Shi, et al.. (2021). Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysis. Bone Marrow Transplantation. 56(10). 2567–2574. 5 indexed citations

16.

Hamed, Rama Al, Abdul Hamid Bazarbachi, Ali Bazarbachi, et al.. (2021). Comprehensive Review of AL amyloidosis: some practical recommendations. Blood Cancer Journal. 11(5). 97–97. 53 indexed citations

17.

Stocker, Nicolas, Rémy Duléry, Giorgia Battipaglia, et al.. (2019). Impact of cyclosporine A concentration on acute graft‐vs‐host disease incidence after haploidentical hematopoietic cell transplantation. European Journal Of Haematology. 103(1). 10–17. 13 indexed citations

18.

Labopin, Myriam, Simona Lapusan, Françoise Isnard, et al.. (2017). Fractionated Gemtuzumab Ozogamicin in Association with High Dose Chemotherapy: A Bridge to Allogeneic Stem Cell Transplantation in Refractory and Relapsed Acute Myeloid Leukemia?. Blood. 130. 4603–4603. 1 indexed citations

19.

Saas, Philippe, Baptiste Lamarthée, Florent Malard, et al.. (2015). Impact of donor hematopoietic cells mobilized with G-CSF and plerixafor on murine acute graft-versus-host-disease. Cytotherapy. 17(7). 948–955. 8 indexed citations

20.

Avet‐Loiseau, Hervé, Florent Malard, L. Campion, et al.. (2010). Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?. Blood. 117(6). 2009–2011. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact